Cerebrospinal fluid tau protein as a potential diagnostic marker in Alzheimer's disease

被引：16

作者：

Arai, H ^{[1
]}

Clark, CM

Ewbank, DC

Takase, S

Higuchi, S

Miura, M

Seki, H

Higuchi, M

Matsui, T

Lee, VMY

Trojanowski, JQ

Sasaki, H

机构：

[1] Tohoku Univ, Sch Med, Dept Geriatr Med, Sendai, Miyagi 980, Japan

[2] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA

[3] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA

[4] Kohnan Hosp, Dept Neurol, Sendai, Miyagi 981, Japan

[5] Kurihama Natl Hosp, Natl Inst Alcoholism, Dept Psychiat, Yokosuka, Kanagawa 239, Japan

[6] Mitsubishi Kagaku Bioclin Labs, Dept Res & Dev, Tokyo 174, Japan

[7] Univ Penn, Dept Pathol & Lab Med, Div Anat Pathol, Philadelphia, PA 19104 USA

来源：

NEUROBIOLOGY OF AGING | 1998年 / 19卷 / 02期

关键词：

D O I：

10.1016/S0197-4580(98)00018-9

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：125 / 126

页数：2

共 14 条

[1] Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease [J].

Arai, H ;

Terajima, M ;

Miura, M ;

Higuchi, S ;

Muramatsu, T ;

Matsushita, S ;

Machida, N ;

Nakagawa, T ;

Lee, VMY ;

Trojanowski, JQ ;

Sasaki, H .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (10) :1228-1231

[2] TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].

ARAI, H ;

TERAJIMA, M ;

MIURA, L ;

HIGUCHI, S ;

MURAMATSU, T ;

MACHIDA, N ;

SEIKI, H ;

TAKASE, S ;

CLARK, CM ;

LEE, VMY ;

TROJANOWSKI, JQ ;

SASAKI, H .

ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652

[3] Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology [J].

Arai, H ;

Morikawa, Y ;

Higuchi, M ;

Matsui, T ;

Clark, CM ;

Miura, M ;

Machida, N ;

Lee, VMY ;

Trojanowski, JQ ;

Sasaki, H .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) :262-264

[4]

ARAI H, 1996, 26 ANN M SOC NEUR AB, V22, P1422

[5]

ARAI H, 1997, ALZHEIMERS RES, V3, P211

[6] Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease [J].

Galasko, D ;

Clark, C ;

Chang, L ;

Miller, B ;

Green, RC ;

Motter, R ;

Seubert, P .

NEUROLOGY, 1997, 48 (03) :632-635

[7] INCREASED LEVELS OF TAU-PROTEIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE - CORRELATION WITH DEGREE OF COGNITIVE IMPAIRMENT [J].

HOCK, C ;

GOLOMBOWSKI, S ;

NASER, W ;

MULLERSPAHN, F .

ANNALS OF NEUROLOGY, 1995, 37 (03) :414-415

[8] INCREASED CEREBROSPINAL-FLUID TAU IN PATIENTS WITH ALZHEIMERS-DISEASE [J].

JENSEN, M ;

BASUN, H ;

LANNFELT, L .

NEUROSCIENCE LETTERS, 1995, 186 (2-3) :189-191

[9] REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE [J].

MOTTER, R ;

VIGOPELFREY, C ;

KHOLODENKO, D ;

BARBOUR, R ;

JOHNSONWOOD, K ;

GALASKO, D ;

CHANG, L ;

MILLER, B ;

CLARK, C ;

GREEN, R ;

OLSON, D ;

SOUTHWICK, P ;

WOLFERT, R ;

MUNROE, B ;

LIEBERBURG, I ;

SEUBERT, P ;

SCHENK, D .

ANNALS OF NEUROLOGY, 1995, 38 (04) :643-648

[10] Disturbed consciousness and asthma [J].

Ohrui, T ;

Yamaya, M ;

Arai, H ;

Sekizawa, K ;

Sasaki, H .

LANCET, 1997, 349 (9052) :652-652

← 1 2 →